Chet Hammill

Dr. Chet Hammill

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2011 in Annals of Surgery
Verified
Journal Article
Closed access
JMJun Ma
Jun Ma
MCMaria A. Cassera
Maria A. Cassera
GSGeorg O. Spaun
Georg O. Spaun
CHChet Hammill
Chet Hammill
PHPaul D. Hansen
Paul D. Hansen
SAShaghayegh Aliabadi-Wahle
Shaghayegh Aliabadi-Wahle
To compare short-term surgical outcomes and quality of life (QOL) between single-port laparoscopic cholecystectomy (SPLC) and classic 4-port laparoscopic cholecystectomy (CLC). There is significant interest in further reducing the trauma associated with surgical procedures. Although a number of observational studies have suggested that SPLC is a feasible alternative to CLC, there is a lack of data from randomized studies validating any benefit over CLC. Eligible patients were randomized to receive SPLC or CLC. Operative and perioperative outcomes, including cosmesis and QOL were analyzed. Forty-three patients were randomized to SPLC (n = 21) or CLC (n = 22). There were no significant differences between groups for most preoperative demographics, American Society of Anesthesiology score, gallstone characteristics, local inflammation, blood loss, or length of stay. Patients undergoing SPLC were older than those receiving CLC (57.3 years vs. 45.8 years, P < 0.05). Operative times for SPLC were greater than CLC (88.5 minutes vs. 44.8 minutes, P < 0.05). Overall and cosmetic satisfaction, QOL as determined by the SF-36 survey, postoperative complications, and post-operative pain scores between discharge and 2-week postoperative visit were not significantly different between groups. Wound infection rates were similar in both groups. The SPLC group contained 1 retained bile duct stone, 1-port site hernia, and 1 postoperative port site hemorrhage. SPLC procedure time was longer and incurred more complications than CLC without significant benefits in patient satisfaction, postoperative pain and QOL. SPLC may be offered in carefully selected patients. Larger randomized trials performed later in the learning curve with SPLC may identify more subtle advantages of one method over another.

1 September 2012 in The American Journal of Surgery
Verified
Journal Article
Closed access
CEC. Kristian Enestvedt
C. Kristian Enestvedt
BDBrian S. Diggs
Brian S. Diggs
MCMaria A. Cassera
Maria A. Cassera
CHChet Hammill
Chet Hammill
PHPaul D. Hansen
Paul D. Hansen
RWRonald F. Wolf
Ronald F. Wolf

16 August 2016 in Journal for ImmunoTherapy of Cancer
Verified
Journal Article
Open access
PDF file
TCTodd Crocenzi
Todd Crocenzi
BCBenjamin Cottam
Benjamin Cottam
PNPippa Newell
Pippa Newell
RWRonald F. Wolf
Ronald F. Wolf
PHPaul D. Hansen
Paul D. Hansen
MCMarka R. Crittenden
Marka R. Crittenden
Background Preclinical studies have shown synergy between radiation therapy and immunotherapy. However, in almost all preclinical models, radiation is delivered in single doses or short courses of high doses (hypofractionated radiation). By contrast in most clinical settings, radiation is delivered as standard small daily fractions of 1.8-2 Gy to achieve total doses of 50–54 Gy (fractionated radiation). We do not yet know the optimal dose and scheduling of radiation for combination with chemotherapy and immunotherapy. Methods To address this, we analyzed the effect of neoadjuvant standard fractionated and hypofractionated chemoradiation on immune cells in patients with locally advanced and borderline resectable pancreatic adenocarcinoma. Results We found that standard fractionated chemoradiation resulted in a significant and extended loss of lymphocytes that was not explained by a lack of homeostatic cytokines or response to cytokines. By contrast, treatment with hypofractionated radiation therapy avoided the loss of lymphocytes associated with conventional fractionation. Conclusion Hypofractionated neoadjuvant chemoradiation is associated with reduced systemic loss of T cells. Trial registration ClinicalTrials.gov NCT01342224, April 21, 2011; NCT01903083, July 2, 2013.

8 March 2024 in Science
Verified
Journal Article
Closed access
JLJiaqi Liu
Jiaqi Liu
Naijia LiuNaijia Liu
Naijia Liu
YXYameng Xu
Yameng Xu
MWMingzheng Wu
Mingzheng Wu
HZHaohui Zhang
Haohui Zhang
JRJohn A. Rogers
John A. Rogers
Monitoring homeostasis is an essential aspect of obtaining pathophysiological insights for treating patients. Accurate, timely assessments of homeostatic dysregulation in deep tissues typically require expensive imaging techniques or invasive biopsies. We introduce a bioresorbable shape-adaptive materials structure that enables real-time monitoring of deep-tissue homeostasis using conventional ultrasound instruments. Collections of small bioresorbable metal disks distributed within thin, pH-responsive hydrogels, deployed by surgical implantation or syringe injection, allow ultrasound-based measurements of spatiotemporal changes in pH for early assessments of anastomotic leaks after gastrointestinal surgeries, and their bioresorption after a recovery period eliminates the need for surgical extraction. Demonstrations in small and large animal models illustrate capabilities in monitoring leakage from the small intestine, the stomach, and the pancreas.

7 December 2018 in Surgical Endoscopy
Verified
Journal Article
Closed access
PDF file
WAWalaa F. Abdelmoaty
Walaa F. Abdelmoaty
CDChristy M. Dunst
Christy M. Dunst
CNChris Neighorn
Chris Neighorn
LSLee L. Swanstrom
Lee L. Swanstrom
CHChet Hammill
Chet Hammill

19 April 2024 in Science Advances
Verified
Journal Article
Open access
Shuo LiShuo Li
Shuo Li
DLDi Lu
Di Lu
SLShupeng Li
Shupeng Li
JLJiaqi Liu
Jiaqi Liu
YXYameng Xu
Yameng Xu
JRJohn A. Rogers
John A. Rogers
Continuous monitoring of biomarkers at locations adjacent to targeted internal organs can provide actionable information about postoperative status beyond conventional diagnostic methods. As an example, changes in pH in the intra-abdominal space after gastric surgeries can serve as direct indicators of potentially life-threatening leakage events, in contrast to symptomatic reactions that may delay treatment. Here, we report a bioresorbable, wireless, passive sensor that addresses this clinical need, designed to locally monitor pH for early detection of gastric leakage. A pH-responsive hydrogel serves as a transducer that couples to a mechanically optimized inductor-capacitor circuit for wireless readout. This platform enables real-time monitoring of pH with fast response time (within 1 hour) over a clinically relevant period (up to 7 days) and timely detection of simulated gastric leaks in animal models. These concepts have broad potential applications for temporary sensing of relevant biomarkers during critical risk periods following diverse types of surgeries.